Fig. 3From: Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysisKaplan Meier OS analysis, from date of incident aNSCLC diagnosis. Shows the Kaplan Meier survival estimates from incident aNSCLC diagnosis for the overall aNSCLC patient sample as well as for subgroups based on mutation testing and received treatments. For assignment of patients to treatments, line of therapy did not matter. Log-rank test: Chemotherapy only/No therapy: p = 0.001; Chemotherapy only/Mutation positive & targeted therapy: p < 0.001; Chemotherapy only/Immunotherapy only p < 0.001; Chemotherapy only/No mutation test & targeted therapy: p = 0.006Back to article page